Dennis Raymond Stanworth

Title: Dennis Raymond Stanworth: Innovator in Immunodiagnostic Assays

Introduction

Dennis Raymond Stanworth is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of immunodiagnostics, particularly in the diagnosis of rheumatoid arthritis. His innovative approach has led to the development of a unique assay that enhances the detection of this condition.

Latest Patents

Stanworth holds a patent for an "Immunodiagnostic assay for rheumatoid arthritis." This assay utilizes a reference to the IgA-.alpha..sub.1 antitrypsin complex present in analytes, facilitated by novel antibody reagents. These reagents are ligands that comprise an antibody domain specific for an antigenic determinant of the complex of human IgA and .alpha..sub.1-antitrypsin. Importantly, this antibody domain is substantially non-reactive with free human IgA and free human .alpha..sub.1-antitrypsin. The invention also includes monoclonal antibodies to the naturally occurring IgA-.alpha..sub.1 AT complex and monoclonal or polyclonal antibodies to a synthetic peptide, which is part of the invention. The synthetic peptide has the amino acid sequence: Val-Ser-Val-Val-Met-Ala-Glu-Val-Asp-Gly-Thr-Cys-Tyr (SEQ ID NO:2).

Career Highlights

Stanworth is associated with Peptide Therapeutics Limited, where he has been instrumental in advancing research and development in the field of immunodiagnostics. His work has not only contributed to scientific knowledge but also has practical implications for the diagnosis and management of rheumatoid arthritis.

Collaborations

Some of his notable coworkers include Ian Victor Lewin and Sarita Nayyar, who have collaborated with him on various projects within the company.

Conclusion

Dennis Raymond Stanworth's innovative contributions to immunodiagnostic assays exemplify the impact of dedicated inventors in the medical field. His patent for the assay of rheumatoid arthritis showcases his commitment to improving diagnostic methods and patient care.